MedPath
TGA Approval

AVAPRO HCT 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack (102086)

102086

AVAPRO HCT 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack

Sanofi-Aventis Australia Pty Ltd

May 18, 2005

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/56918ceb982ae8934d55f57e502a83c6.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/378e4129c209ec2715ee5bbe409a1202.pdf

Active Ingredients

hydrochlorothiazide

irbesartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AVAPRO HCT 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack (102086) - TGA 批准文号 | MedPath